MedCity News December 27, 2024
Marissa Plescia

Fidelity Management & Research Company and Dexcom participated in ŌURA’s $200 million Series D round.

ŌURA, a wearable device company, has secured $200 million in Series D funding to expand its product offerings, the company announced last week.

ŌURA, which was founded in Finland in 2013, offers a wearable smart ring called the Oura Ring, as well as an accompanying app. The ring provides personalized insights and guidance on sleep, activity, readiness, stress, resilience, women’s health and heart health. People can purchase an Oura Ring starting at $249.

Fidelity Management & Research Company and Dexcom, a continuous glucose monitoring company, participated in ŌURA’s $200 million Series D round. To date, ŌURA has raised more than $550 million, and its Series...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, Investments, Technology, Trends, Wearables
Flattening the curve: How smartwatches could help stop a pandemic before it even begins
Unlocking the power of sensor data in type 2 diabetes care
Google’s Pixel Watch 3 Loss of Pulse Detection Feature Receives FDA Clearance
10 Ways Technology is Changing Healthcare - 3
Yhprum's Law applied to Healthcare Technology: Celebrate the unexpected victories because "Everything that can work, will work"

Share This Article